By Mill Chart
Last update: Nov 6, 2023
JOHNSON & JOHNSON (NYSE:JNJ) was identified as a stock worth exploring by dividend investors by our stock screener. NYSE:JNJ scores well on profitability, solvency and liquidity. At the same time it seems to pay a decent dividend. We'll explore this a bit deeper below.
ChartMill assigns a proprietary Dividend Rating to each stock. The score is computed by evaluating various valuation aspects, like the yield, the history, the dividend growth and sustainability. NYSE:JNJ was assigned a score of 7 for dividend:
ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NYSE:JNJ, the assigned 7 for health provides valuable insights:
ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:JNJ, the assigned 9 is noteworthy for profitability:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
Our latest full fundamental report of JNJ contains the most current fundamental analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
JOHNSON & JOHNSON
NYSE:JNJ (4/26/2024, 7:04:00 PM)
After market: 145.9 -0.24 (-0.16%)146.14
-0.68 (-0.46%)
These healthcare stocks can provide enviable long-term portfolio growth.
One thing is for sure: Dividend seekers can't go wrong with either.
Is this top healthcare stock worth adding to your portfolio today?
The latest inflation readings showed consumers won't get low prices anytime soon, here are seven stocks to buy if inflation continues to rise
These three long-term stocks to buy promise decades of gains and are poised to enhance your generational wealth.
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Curious to know how much these dividend aristocrats could grow in the next year? Here's the answer for several well-known shares.
With global markets facing a wave of uncertainty, it’s appropriate for investors to consider these steady stocks.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors don’t have to look far to find justification for investing in&n...
These top small-cap stocks offer investors diversification across multiple segments but boast a strong standing on their own merits.
Pounce before it is too late! Build a robust portfolio with these three long-term stocks to buy on the dip.
Why JOHNSON & JOHNSON (NYSE:JNJ) is a Top Pick for Dividend Investors.